韶能股份表示，此次交易预计将有助于公司盘活资产、提升经营效率。鉴于本次以公开挂牌方式转让标的资产，处置完成情况存在不确定性，预计获得的 损益及对公司本期和未来财务状况和经营成果的影响暂无法确定，具体影响金额以处置完成后会计师年度审计结果为准。 12月5日晚间，韶能股份（000601）发布公告称，为优化业务结构，提升经营效率，降低管理成本，回笼资金聚焦主业发展，公司拟将名下15处房产对外 公开挂牌转让。经韶关市鼎顺房地产与土地评估有限公司评估，这批房产评估总价为1654.70万元，公开挂牌转让价以评估价为基础，最终以实际成交价 为准。 公告显示，公司此次拟出售的15处房产均位于韶关市。从分布来看，标的资产集中于韶关市核心区域，其中武江区占比较高，涵盖工业中路、芙蓉北路等 地段，韶关市浈江区十里亭镇靖村也有3处资产纳入处置范围。房产用途包括住宅、非住宅、办公等。 据公告，公司本次拟出售的15处房产总计面积为13358.17平方米，按照1654.7万元的最终评估值来计算，每平米的均价仅1238.72元。 公司称，本次拟挂牌交易的房产不存在抵押、质押或者其他第三人权利，不存在涉及重大争议、诉讼或仲裁事项，不存在查封、 ...

每经记者｜蔡鼎 每经编辑｜何小桃 廖丹 韶能股份（SZ000601，股价5.12元，市值54.49亿元）12月5日晚间公告称，为优化业务结构，提升经营效率，降低管理成本，回笼资金聚焦主业发展，公 司拟将名下15处房产对外公开挂牌转让。这批房产评估总价为1654.7万元，公开挂牌转让价以评估价为基础，最终以实际成交价为准。 据公告，上述出售房产议案已由韶能股份召开的第十一届董事会第三十一次临时会议全票审议通过，本次交易无需提交公司股东会审批。此外，本次交易 不涉及关联交易，亦不构成重大资产重组。 15处房产中12处位于韶关市武江区 韶能股份公告显示，公司此次拟出售的15处房产均位于韶关市。从分布来看，标的资产集中于韶关市核心区域，其中武江区占比较高，涵盖工业中路、芙 蓉北路等地段，韶关市浈江区十里亭镇靖村也有3处资产纳入处置范围。 从用途分类来看，包含成套住宅7套、普通住宅1套、办公用房4处、非住宅2处，另有生产、附属设施用地1处。 此前已出售多个资产 据韶能股份2025年半年报，公司主营业务主要聚焦于三大板块：清洁可再生能源（新能源）、生态植物纤维制品 (如纸制品、纸浆)、精密（智能）制造， 同时覆盖电力、供 ...

Group 1 - The company is currently in the execution phase of a lawsuit against Guangzhou Dongzhan Real Estate Development Co., Ltd. and others, with a claimed amount of 335 million yuan and interest [2][3] - The company has received a court ruling in its favor for the majority of its claims, including a principal loan amount of 335 million yuan [5][6] - The company has been granted the right to offset debts with a property valued at 568,794 yuan, following unsuccessful auction attempts [9][10] Group 2 - The company has accumulated an asset impairment provision of 307.155 million yuan against its investment in Dongzhan as of June 30, 2025 [2][10] - The company will continue to monitor the situation and will conduct impairment testing based on accounting standards [10] - The company has previously made impairment provisions of 144.413 million yuan, 74.454 million yuan, 85.396 million yuan, 1.404 million yuan, and 1.488 million yuan in the years leading up to 2025 [10] Group 3 - The company plans to sell its holdings in various stocks, including 8,685,953 shares of Guizhou Yibai Pharmaceutical, 970,605 shares of Aoride, 7,716 shares of China Ping An, and 4,712,205 shares of Erkang Pharmaceutical, with a total expected sale price of no less than 46.948 million yuan [14][26] - The company aims to optimize its asset structure and improve liquidity through this sale, which is expected to account for over 50% of its audited net profit from the previous year [26][40] - The sale is subject to shareholder approval and will be executed based on market conditions [24][26] Group 4 - The company intends to publicly transfer 41% of its stake in Guangdong Yihua Real Estate Development Co., Ltd. at a minimum price of 1 yuan due to the inability to obtain financial data from Yihua [44][45] - The company has assessed that the investment in Yihua has been impaired to zero, leading to the decision to sell [47][54] - The transaction will not significantly impact the company's financial status or operations and is expected to align with its strategic focus on core business areas [57][86] Group 5 - The company plans to transfer its debt assets related to Guangzhou Zhongqiao Investment Holding Group Co., Ltd. to Guangzhou Zhujiang Real Estate Group Co., Ltd. for 333.6236 million yuan [59][66] - This transaction is classified as a related party transaction but does not constitute a major asset restructuring [59][86] - The company aims to streamline its asset management and focus on its main business operations through this transfer [60][86]

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 10.77 RMB [7][8]. Core Views - The company achieved a revenue of 103.06 billion RMB in 2024, a year-on-year decrease of 27.27%, while the net profit attributable to shareholders increased by 90.05% to 474 million RMB [1][2]. - The focus on core business operations has led to significant operational optimization, with expectations for continued cost reduction and improved financial stability [1][3]. - The company’s pig farming business has shown a substantial reduction in losses due to rising pig prices and cost optimization, while the feed business remains a stable profit contributor [2][3]. Summary by Sections Financial Performance - In 2024, the feed segment generated 68.7 billion RMB in revenue, down 15% year-on-year, while the pig farming segment saw a revenue increase of 43% to 30.4 billion RMB [2]. - The average weaning cost per pig decreased by 90 RMB to 290 RMB, and the average survival rate for fattening pigs improved to 92% [3]. Profit Forecast and Valuation - The report adjusts the profit forecast for 2025 and 2026, predicting net profits of 1.35 billion RMB and 440 million RMB respectively, with a new forecast for 2027 introduced [4]. - The target price of 10.77 RMB corresponds to a price-to-book ratio of 1.89 for 2025, reflecting the company's improving financial condition and operational metrics [4][8].